Continuous Glucose Monitoring and the Opportunities for Optimal Diabetes Care and Cost Management
Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.
Impact Education, LLC     Medical Education Resources
This activity is supported by an independent educational grant from Dexcom.

You Are Invited to a LIVE CME/CPE/CNE Webcast Series:
Continuous Glucose Monitoring and the Opportunities for Optimal Diabetes Care and Cost Management

Live Webcast Date

DAY DATE TIME
Monday November 18, 2019 12:00 PM - 1:30 PM ET


EXPERT FACULTY PRESENTERS

Osama S. Eisa, MD
Senior Medical Director
Cigna HealthSpring
Estay Greene, PharmD
Vice President, Pharmacy Services
Blue Cross Blue Shield of North Carolina
Anita Swamy, MD
Medical Director, Chicago Children's Diabetes Center
Associate Clinician, Lurie Children's
Assistant Professor of Pediatrics, Northwestern Feinberg School of Medicine
Douglas McKell, MS, MSc, PgC HEOR
Moderator
Impact Education, LLC.

TARGET AUDIENCE
  • Medical directors, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations
  • Pharmacy directors, registered nurses, quality directors, care managers, and other managed care and payer organization professionals
PROGRAM OVERVIEW

The vast majority of plan members with diabetes have an A1C above ADA targets, putting them at risk for other costly comorbidities. To effectively address these clinical challenges and elicit improvements across 29 indices of glycemic control and glycemic variability, continuous glucose monitoring (CGM) has been endorsed by various professional endocrinology-centered organizations. In 2017, the Centers for Medicare and Medicaid Services (CMS) Medicare made a milestone ruling, establishing benefit coverage for therapeutic CGM — a designation applying to those CGM systems approved for use in making treatment decisions without a fingerstick (non-adjunctive use). This program will elucidate the burden of diabetes and describe multifaceted clinical and administrative strategies across the medical and pharmacy benefits to promote quality care and manage costs while improving outcomes for affected plan members.

EDUCATIONAL OBJECTIVES

After completing the activity, participants should be better able to:
  • Characterize the clinical and economic burden of diabetes in terms of health care resource utilization, indirect costs, and member quality of life
  • Describe the value of appropriate, evidence-based clinical interventions for managing morbidity and minimizing direct expenditures in other categories
  • Review the available consensus recommendations regarding evidence-based care in the management of diabetes
  • Characterize the role and value of CGM as part of a comprehensive diabetes management strategy
  • Discuss the adverse effect of specific benefit design schema and excess cost-sharing on patient access and adherence to clinical interventions
  • Employ pharmacy and medical benefit design strategies that account for the heterogeneity of patient populations and optimize outcomes
AGENDA
Opening Comments/Overview
Douglas McKell, MS, MSc, PgC HEOR
The Value of Glucose Monitoring Systems as Part of a Comprehensive Management Strategy
Osama S. Eisa, MD
Evidence-based Diabetes Management and Monitoring Recommendations
Anita Swamy, MD
Pharmacy Benefit Management Strategies to Enhance Outcomes through Appropriate Coverage of CGM and Other Technology Interventions
Estay Greene, PharmD
Audience Q&A Session
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation

ACCREDITATION INFORMATION

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Credit
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0816-9999-19-177-L01-P
This activity is certified as Knowledge-based CPE.

Continuing Nursing Education
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This CE activity provides 1.5 contact hours of continuing nursing education.

Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 1.5 contact hours.


Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Name of Faculty Reported Financial Relationships
Osama S. Eisa, MD Coming soon
Estay Greene, PharmD No financial interest/relationships relating to the topic of this activity
Anita Swamy, MD Consulting Fees (eg. ad boards) - Novo Nordisk
Speakers' Bureau - Novo Nordisk, Insulet and Dexcom
Douglas McKell, MS, MSc, PgC HEOR No financial interest/relationships relating to the topic of this activity

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Name of Content Manager Reported Financial Relationships
Impact Education, LLC. Content Managers No financial interest/relationships relating to the topic of this activity
MER Content Managers No financial interest/relationships relating to the topic of this activity


Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.